IPSC vs TMO · rev $6.6M vs P/E 24, rev $44.56B
Century Therapeutics Inc (IPSC) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
IPSC currently screens at market cap $47.8M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the IPSC and TMO stock pages for the full models.
Not investment advice.